{"doc_id": "si-2021-0043-reg-1", "parent_doc_id": "si-2021-0043", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 43 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "1. (1) These Regulations may be cited as the Medicinal Products", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products \n\n(Prescription and Control of Supply) (Amendment) (No. 3) Regulations 2021. \n\n(2) The collective citation “the Medicinal Products (Prescription and Control \n\nof Supply) Regulations 2003 to 2021” includes these Regulations.", "text_norm": "1 (1) regulation may cited medicinal product (prescription control supply) (amendment) (no 3) regulation 2021 (2) collective citation medicinal product (prescription control supply) regulation 2003 2021 includes regulation", "start_char": 637, "end_char": 927, "source_path": "downloads\\2021\\2021_0043.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ff5121762627b5bef34b89d4c969c2586b6a7290d8e4d0440877358885fbbe26", "cross_refs": []}
{"doc_id": "si-2021-0043-reg-2", "parent_doc_id": "si-2021-0043", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 43 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "In these Regulations—", "text_raw": "2. \n\nIn these Regulations— \n\n“Principal Regulations” means the Medicinal Products (Prescription and Control \nof Supply) Regulations 2003 (S.I. No. 540 of 2003); \n\n“Regulations of 2021” means the Medicinal Products (Prescription and Control \nof Supply) (Amendment) (No. 2) Regulations 2021 (S.I. No. 8 of 2021). \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 9th February, 2021. \n\n \n \n \n \n \n \n \n \n\f[43] 3", "text_norm": "2 regulations-- principal regulation mean medicinal product (prescription control supply) regulation 2003 (s.i no 540 2003) regulation 2021 mean medicinal product (prescription control supply) (amendment) (no 2) regulation 2021 (s.i no 8 2021) notice making statutory instrument published iris oifigiuil 9th february 2021 43 3", "start_char": 927, "end_char": 1376, "source_path": "downloads\\2021\\2021_0043.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ff5121762627b5bef34b89d4c969c2586b6a7290d8e4d0440877358885fbbe26", "cross_refs": []}
{"doc_id": "si-2021-0043-reg-3", "parent_doc_id": "si-2021-0043", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 43 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "3. The Eighth Schedule (as amended by Regulation 3 of the Regulations of", "text_raw": "3. The Eighth Schedule (as amended by Regulation 3 of the Regulations of \n2021) to the Principal Regulations is amended by inserting the following entry: \n\n“ \n\nMedicinal \nProduct \n\nForm and \npresentation \nof product \nadministered \n\nRoute of \nadministration \n\nIndication for \nwhich the \nmedicinal \nproduct may \nbe \nadministered \n\nDosage and \nconditions of \nadministration \n\nPlace of \nadministration \n\nColumn 1 \n\nColumn 2 \n\nColumn 3 \n\nColumn 4 \n\nColumn 5 \n\nColumn 6 \n\nIntramuscular \n(IM) injection \nonly. \n\nCOVID-19 \nVaccine \nAstraZeneca, \nsuspension for \ninjection \n\nCOVID-19 \nVaccine \n(ChAdOx1-S \n[recombinant]). \n\nSuspension \nfor injection. \n\nThe \nsuspension is \ncolourless to \nslightly \nbrown, clear \nto slightly \nopaque with a \npH of 6.6. \n\nIn accordance \nwith the \nsummary of \nproduct \ncharacteristics \nof the product \nadministered \nand relevant \nnational \nguidelines. \n\nCOVID-19 \nVaccine \nAstraZeneca \nis indicated \nfor active \nimmunisation \nto prevent \nCOVID 19 \ncaused by \nSARS CoV 2, \nin individuals \n18 years of \nage and older. \n\nAny suitable \nand \nappropriate \nplace, having \nregard to \npublic \nconvenience \nand the need \nto protect the \nhealth and \nsafety of the \npublic and \nsafely \nadminister the \nproduct. \n\n”. \n\n \n \n \n\f4 [43]", "text_norm": "3 eighth schedule (as amended regulation 3 regulation 2021) principal regulation amended inserting following entry medicinal product form presentation product administered route administration indication medicinal product may administered dosage condition administration place administration column 1 column 2 column 3 column 4 column 5 column 6 intramuscular (im) injection only covid-19 vaccine astrazeneca suspension injection covid-19 vaccine (chadox1-s recombinant ) suspension injection suspension colourless slightly brown clear slightly opaque ph 6.6 accordance summary product characteristic product administered relevant national guideline covid-19 vaccine astrazeneca indicated active immunisation prevent covid 19 caused sars cov 2 individual 18 year age older suitable appropriate place regard public convenience need protect health safety public safely administer product  4 43", "start_char": 1376, "end_char": 2619, "source_path": "downloads\\2021\\2021_0043.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ff5121762627b5bef34b89d4c969c2586b6a7290d8e4d0440877358885fbbe26", "cross_refs": []}
{"doc_id": "si-2021-0043-reg-4", "parent_doc_id": "si-2021-0043", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 43 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "4. The Twelfth Schedule (as amended by Regulation 4 of the Regulations", "text_raw": "4. The Twelfth Schedule (as amended by Regulation 4 of the Regulations \nof 2021) to the Principal Regulations is amended by inserting the following \nentry: \n\n“ \n\nMedicinal Product Form and \n\npresentation of \nproduct \nadministered \n\nRoute of \nadministration \n\nIndication for \nwhich the \nmedicinal \nproduct may be \nadministered \n\nDosage and \nconditions of \nadministration \n\nColumn 1 \n\nColumn 2 \n\nColumn 3 \n\nColumn 4 \n\nColumn 5 \n\nIntramuscular \n(IM) injection \nonly. \n\nCOVID-19 \nVaccine \nAstraZeneca, \nsuspension for \ninjection \n\nCOVID-19 \nVaccine \n(ChAdOx1-S \n[recombinant]). \n\nSuspension for \ninjection. \n\nThe suspension \nis colourless to \nslightly brown, \nclear to \nslightly opaque \nwith a pH of", "text_norm": "4 twelfth schedule (as amended regulation 4 regulation 2021) principal regulation amended inserting following entry medicinal product form presentation product administered route administration indication medicinal product may administered dosage condition administration column 1 column 2 column 3 column 4 column 5 intramuscular (im) injection only covid-19 vaccine astrazeneca suspension injection covid-19 vaccine (chadox1-s recombinant ) suspension injection suspension colourless slightly brown clear slightly opaque ph", "start_char": 2619, "end_char": 3316, "source_path": "downloads\\2021\\2021_0043.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ff5121762627b5bef34b89d4c969c2586b6a7290d8e4d0440877358885fbbe26", "cross_refs": []}
{"doc_id": "si-2021-0043-reg-6", "parent_doc_id": "si-2021-0043", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 43 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "COVID-19", "text_raw": "6.6. \n\nCOVID-19 \nVaccine \nAstraZeneca is \nindicated for \nactive \nimmunisation to \nprevent COVID \n19 caused by \nSARS CoV 2, in \nindividuals 18 \nyears of age and \nolder. \n\nIn accordance \nwith the \nsummary of \nproduct \ncharacteristics \nof the product \nadministered \nand relevant \nnational \nguidelines. \n\n”. \n\nGIVEN under my Official Seal, \n\n4 February, 2021. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n\f[43] 5", "text_norm": "6.6 covid-19 vaccine astrazeneca indicated active immunisation prevent covid 19 caused sars cov 2 individual 18 year age older accordance summary product characteristic product administered relevant national guideline  given official seal 4 february 2021 stephen donnelly minister health 43 5", "start_char": 3316, "end_char": 3750, "source_path": "downloads\\2021\\2021_0043.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ff5121762627b5bef34b89d4c969c2586b6a7290d8e4d0440877358885fbbe26", "cross_refs": []}
{"doc_id": "si-2021-0043-explanatory-note", "parent_doc_id": "si-2021-0043", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 43 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003. \n\nThe purpose of these Regulations is to add an additional Covid-19 vaccination \nto the Eighth and Twelfth Schedules to the Regulations of 2003. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 3) Regulations 2021. \n\n \n \n \n \n \n \n \n \n\f6 [43] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \n52 FAICHE STIABHNA, BAILE ÁTHA CLIATH 2, \nD02 DR67. \n\nTeil: 076 110 6834 \nr-post: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \n52 ST. STEPHEN'S GREEN, DUBLIN 2, \nD02 DR67. \n\nTel: 076 110 6834 \nE-mail: publications@opw.ie \n—————— \n\n€3.00 \n\n(DH-203) 75. 2/21. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 purpose regulation add additional covid-19 vaccination eighth twelfth schedule regulation 2003 regulation may cited medicinal product (prescription control supply) (amendment) (no 3) regulation 2021 6 43 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais 52 faiche stiabhna baile atha cliath 2 d02 dr67 teil 076 110 6834 r-post publication opw.ie ------------ dublin published stationery office purchased government publication 52 st stephen green dublin 2 d02 dr67 tel 076 110 6834 e-mail publication opw.ie ------------ eur3.00 (dh-203) 75 2 21 propylon", "start_char": 3750, "end_char": 4724, "source_path": "downloads\\2021\\2021_0043.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ff5121762627b5bef34b89d4c969c2586b6a7290d8e4d0440877358885fbbe26", "cross_refs": []}
